Visit-ready
Keep authorization and coverage aligned before the appointment is booked.
Streamline split-facility fees, preventative screening modifier transitions, and pathology lab results charge triggers. See why gastroenterology practices choose Unlimited Systems for practice management and RCM software.
Gastroenterology clinics face intense workflow splits between outpatient clinical consultations, on-site pathology laboratories, and complex Endoscopy/Colonoscopy procedures performed at separate ambulatory surgery centers.
A screening colonoscopy that transitions into a diagnostic procedure (due to microscopic snare polypectomies) must be processed with meticulous modifier sequencing (e.g., -33 or -PT modifiers). Mismatching these codes triggers patient balance errors and hefty Medicare rejections.
★★★★★5/5Product screenshot
Gastroenterology workspace preview coming soon
Trusted Payer & EHR Integration Partners
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
Our connected workflows are built to make you and your work easier to do and increase your revenue.
Keep authorization and coverage aligned before the appointment is booked.
Validate gastroenterology codes, modifiers, and documentation before submission.
Give teams one view of denials, margin, and A/R priorities.
IBD biologics and infusion services are the fastest-growing revenue risk.
Where revenue is at risk
Remicade, Entyvio, and Stelara require step therapy from steroids or immunomodulators for many payers.
How the platform addresses this
| Drug | Code | Route | Channel | Cost | PA | Billing notes |
|---|---|---|---|---|---|---|
| Entyvio (vedolizumab) | J3380 | IV | Part B | $22K/yr | Yes | Step therapy from Remicade often required. |
| Stelara (ustekinumab) | J3357 | IV then SQ | Part B/D | $55K/yr | Yes | IV induction then SQ maintenance creates channel shift. |
| Remicade (infliximab) | J1745 | IV | Part B | $26K/yr | Yes | Biosimilar substitution rules vary by payer. |
| Skyrizi (risankizumab) | J0222 | IV then SQ | Part B/D | $55K/yr | Yes | Newer IV induction; payer policy evolving. |
| Tysabri (natalizumab) | J2323 | IV | Part B | $59K/yr | Yes (TOUCH) | Crohn's indication; REMS adds burden. |
Cabinet integration: GI infusion suites are growing quickly. Without cabinet-to-EHR integration, manual infusion logs miss administration code add-ons and fail to capture infusion duration accurately for high-value IBD drugs.
See how gastroenterology groups across the country use Unlimited Systems to lift collections, cut denials, and reclaim staff time.

“Unlimited Systems gave our gastroenterology billing team the specialty-specific automation we could never get from a generic platform. First-pass claim acceptance climbed fast.”
- Director of Revenue Cycle
Drag the sliders to estimate how much unrealized cash remains locked in your current specialty billing cycles before optimization.
Adjust both inputs to match your practice.
Enter your work email to unlock your estimated annual recovery.
Eight connected capabilities, grouped around the way your practice works.
Keep registration and appointment calendars in sync.
Verify coverage and catch charge risk early.
Post payments, route denials, and prioritize A/R.
See margin, performance, and value-based results.
Each module is configured for the codes, modifiers, and payer rules gastroenterology teams work with, not adapted from generic billing software.
These are the places gastroenterology practices most often lose revenue when their billing platform wasn’t built for the work. Unlimited Systems closes each one with rules configured for your specialty.
Review your workflowCommon gastroenterology revenue leaks
The work that generic platforms leave to your staff is the work gastroenterology margin actually turns on.
See why gastroenterology practices move off general-purpose billing platforms.
You don't have to be actively replacing your current system to have a useful conversation with Unlimited Systems. Many gastroenterology practices talk with us months before a contract renewal or system evaluation to understand where IBD biologic authorization, infusion room billing, endoscopy coding, and pathology coordination may already be showing up.
A conversation can help surface where IBD biologic step therapy, infusion administration add-ons, endoscopy unbundling risk, and pathology professional/technical splits may be reducing your capture rate.
Specialty rules and connected data keep your team focused on the exceptions that need judgment.
Coverage and authorization stay tied to the order.
Code, unit, and modifier checks happen before filing.
Denials and A/R are ranked by value and filing risk.
The same connected system handles the operational work that sits either side of billing.
Digital intake, eligibility, and demographic capture before the visit.
Explore Patient IntakeSmart calendars and resource scheduling across providers and locations.
Explore Patient SchedulingAutomated eligibility checks and prior authorization management.
Explore Financial ClearancePre-claim scrubbing for coding, modifiers, and compliance accuracy.
Explore Charge ValidationEight stages, one record. Nothing is rekeyed between systems, so a detail captured at the front desk is still there when the claim goes out, and when the remittance comes back.
Walk the workflow with usWe map outpatient pathology systems directly to charge logs, triggering tissue-block units based on specimen registrations.
New to revenue cycle terminology? Browse our healthcare RCM & billing glossary.
Practices like yours, on what changed after moving to Unlimited Financials.

I'd love to set up a call to talk about SCOA, and the success we've had with Unlimited Financials.
The system continues to grow with features as it should, with how healthcare changes. So, if you are looking for a company that is innovative and truly cares, I would recommend Unlimited Financials.
Unlimited Financials has been the easiest and best practice management system I have used. It is easy to navigate and do what I need to do.
I would recommend Unlimited Financials to other specialty practices.
We transitioned to Unlimited Financials in 2024... the team and platform are absolutely amazing.
We have been on Unlimited Financials for over three years and love it. Our claims are being processed faster and more efficiently, which means we are receiving payment more quickly.
I'd love to set up a call to talk about SCOA, and the success we've had with Unlimited Financials.
The system continues to grow with features as it should, with how healthcare changes. So, if you are looking for a company that is innovative and truly cares, I would recommend Unlimited Financials.
Unlimited Financials has been the easiest and best practice management system I have used. It is easy to navigate and do what I need to do.
I would recommend Unlimited Financials to other specialty practices.
We transitioned to Unlimited Financials in 2024... the team and platform are absolutely amazing.
We have been on Unlimited Financials for over three years and love it. Our claims are being processed faster and more efficiently, which means we are receiving payment more quickly.
Connect with a specialized Gastroenterology RCM expert for a personal workflow walkthrough, and see where your current setup is creating avoidable revenue risk.
★★★★★5/5